Steven J. Lichtenstein

737 total citations
21 papers, 493 citations indexed

About

Steven J. Lichtenstein is a scholar working on Ophthalmology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Steven J. Lichtenstein has authored 21 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 9 papers in Pharmacology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Steven J. Lichtenstein's work include Ocular Infections and Treatments (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Intraocular Surgery and Lenses (4 papers). Steven J. Lichtenstein is often cited by papers focused on Ocular Infections and Treatments (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Intraocular Surgery and Lenses (4 papers). Steven J. Lichtenstein collaborates with scholars based in United States, China and Saudi Arabia. Steven J. Lichtenstein's co-authors include Michael P. Blair, Michael J. Shapiro, Jennifer Hu, John M. Galasso, R. L. Kapur, John W. Gamel, Ian W. McLean, Richard A. Greenberg, Lorenz E. Zimmerman and David W. Stroman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Ophthalmology.

In The Last Decade

Steven J. Lichtenstein

16 papers receiving 444 citations

Peers

Steven J. Lichtenstein
David T.W. Fei United States
Krishna R. Murthy India
David G. Shulman United States
Wuqaas M. Munir United States
Manish Nagpal United States
Calvin W. Roberts United States
Andreas Mueller Germany
Natasha Buchanan United States
Raffaele Raimondi Italy
Gopal Chandra Ghosh India
David T.W. Fei United States
Steven J. Lichtenstein
Citations per year, relative to Steven J. Lichtenstein Steven J. Lichtenstein (= 1×) peers David T.W. Fei

Countries citing papers authored by Steven J. Lichtenstein

Since Specialization
Citations

This map shows the geographic impact of Steven J. Lichtenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Lichtenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Lichtenstein more than expected).

Fields of papers citing papers by Steven J. Lichtenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Lichtenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Lichtenstein. The network helps show where Steven J. Lichtenstein may publish in the future.

Co-authorship network of co-authors of Steven J. Lichtenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Lichtenstein. A scholar is included among the top collaborators of Steven J. Lichtenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Lichtenstein. Steven J. Lichtenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lichtenstein, Steven J., et al.. (2022). Management of Pediatric Conjunctivitis. Journal of Pediatric Ophthalmology & Strabismus. 59(3). 142–144.
2.
Blair, Michael P., et al.. (2013). Exudative retinopathy and detachment: A late reactivation of retinopathy of prematurity after intravitreal bevacizumab. Journal of American Association for Pediatric Ophthalmology and Strabismus. 17(3). 323–325. 59 indexed citations
3.
Hu, Jennifer, Michael P. Blair, Michael J. Shapiro, et al.. (2012). Reactivation of Retinopathy of Prematurity After Bevacizumab Injection. Archives of Ophthalmology. 130(8). 1000–1000. 217 indexed citations
4.
Lichtenstein, Steven J., et al.. (2011). Topical Ophthalmic Moxifloxacin Elicits Minimal or No Selection of Fluoroquinolone Resistance Among Bacteria Isolated From the Skin, Nose, and Throat. Journal of Pediatric Ophthalmology & Strabismus. 49(2). 88–97.
5.
Wagner, Rudolph S., et al.. (2010). Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin. SHILAP Revista de lepidopterología. 3 indexed citations
6.
Arnold, Robert W., Steven J. Lichtenstein, & Leonard B. Nelson. (2010). Treatment Options for Dense Amblyopia in Uncooperative Children. Journal of Pediatric Ophthalmology & Strabismus. 47(3). 134–138. 1 indexed citations
7.
8.
Lichtenstein, Steven J., et al.. (2007). Safety and Tolerability of Olopatadine 0.2% in Children and Adolescents. Journal of Ocular Pharmacology and Therapeutics. 23(4). 366–371. 9 indexed citations
9.
Lichtenstein, Steven J., et al.. (2007). Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: Clinical implications and a review of kinetics of kill studies. Advances in Therapy. 24(5). 1098–1112. 19 indexed citations
10.
Scoper, Stephen V., Gregg J. Berdy, Steven J. Lichtenstein, et al.. (2007). Perception and quality of life associated with the use of olopatadine 0.2% (Pataday™) in patients with active allergic conjunctivitis. Advances in Therapy. 24(6). 1221–1232. 19 indexed citations
11.
Berdy, Gregg J., Stephen V. Scoper, Steven J. Lichtenstein, et al.. (2007). Once-A-Day Olopatadine Improves the Health-Related Quality-Of-Life of Allergic Conjunctivitis Patients. Journal of Allergy and Clinical Immunology. 119(1). S42–S42. 1 indexed citations
12.
Granet, David B., et al.. (2007). An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.. PubMed. 1(4). 519–25. 11 indexed citations
13.
Lichtenstein, Steven J. & Mark B. Abelson. (2006). Pharmacology, clinical efficacy and safety of olopatadine hydrochloride. Expert Review of Clinical Immunology. 2(3). 341–351. 1 indexed citations
14.
Lichtenstein, Steven J., Mark S. Dorfman, R.D. Kennedy, & David W. Stroman. (2006). Controlling Contagious Bacterial Conjunctivitis. Journal of Pediatric Ophthalmology & Strabismus. 43(1). 19–26. 16 indexed citations
15.
Kowal, Lionel, et al.. (2005). The ophthalmologist and learning disabilities. Queensland's institutional digital repository (The University of Queensland). 23(2). 9–11. 1 indexed citations
16.
Lichtenstein, Steven J., et al.. (2003). Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients. Journal of American Association for Pediatric Ophthalmology and Strabismus. 7(5). 317–324. 30 indexed citations
17.
Schwab, Ivan R., Mitchell H. Friedlaender, James P. McCulley, Steven J. Lichtenstein, & Ciaran Moran. (2003). A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Ophthalmology. 110(3). 457–465. 31 indexed citations
18.
Schwab, Ivan R., Mitchell H. Friedlaender, James P. McCulley, Steven J. Lichtenstein, & Ciaran Moran. (2003). A PHASE III CLINICAL TRIAL OF 0.5% LEVOFLOXACIN OPHTHALMIC SOLUTION VERSUS 0.3% OFLOXACIN OPHTHALMIC SOLUTION FOR THE TREATMENT OF BACTERIAL CONJUNCTIVITIS. Evidence-Based Eye Care. 4(3). 150–151. 3 indexed citations
19.
Gamel, John W., Ian W. McLean, Richard A. Greenberg, Lorenz E. Zimmerman, & Steven J. Lichtenstein. (1982). Computerized histologic assessment of malignant potential: A method for determining the prognosis of uveal melanomas. Human Pathology. 13(10). 893–897. 51 indexed citations
20.
Lichtenstein, Steven J. & G. S. Nettleton. (1980). Effects of fuchsin variants in aldehyde fuchsin staining.. Journal of Histochemistry & Cytochemistry. 28(7). 683–688. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David T.W. Fei Breakdown of academic impact, for papers by Krishna R. Murthy Breakdown of academic impact, for papers by David G. Shulman Breakdown of academic impact, for papers by Wuqaas M. Munir Breakdown of academic impact, for papers by Manish Nagpal Breakdown of academic impact, for papers by Calvin W. Roberts Breakdown of academic impact, for papers by Andreas Mueller Breakdown of academic impact, for papers by Natasha Buchanan Breakdown of academic impact, for papers by Raffaele Raimondi Breakdown of academic impact, for papers by Gopal Chandra Ghosh
Rankless by CCL
2026